These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8110071)

  • 81. Effects of Plasma Proteins on the Transport and Surface Characteristics of Polysulfone/Polyethersulfone and Asymmetric Cellulose Triacetate High Flux Dialyzers.
    Kim TR; Hadidi M; Motevalian SP; Sunohara T; Zydney AL
    Artif Organs; 2018 Nov; 42(11):1070-1077. PubMed ID: 29774568
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Effect of dialysis dose and membrane flux in maintenance hemodialysis.
    Eknoyan G; Beck GJ; Cheung AK; Daugirdas JT; Greene T; Kusek JW; Allon M; Bailey J; Delmez JA; Depner TA; Dwyer JT; Levey AS; Levin NW; Milford E; Ornt DB; Rocco MV; Schulman G; Schwab SJ; Teehan BP; Toto R;
    N Engl J Med; 2002 Dec; 347(25):2010-9. PubMed ID: 12490682
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Low-molecular-weight protein-permeable cuprammonium rayon haemofilter.
    Menth M; Röckel A; Abdelhamid S; Fiegel P; Walb D
    Nephrol Dial Transplant; 1992; 7(8):844-7. PubMed ID: 1325619
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Beta 2-microglobulin associated amyloidosis and therapy with high flux hemodialysis membranes.
    Floege J; Koch KM
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S52-6. PubMed ID: 7923985
    [No Abstract]   [Full Text] [Related]  

  • 85. Reduction of mononuclear cytokine production in hemodialysis patients treated with steam-sterilized low-flux polysulphone membranes.
    Aucella F; Vigilante M; Grandone E; Colaizzo D; Margaglione M; Modoni S; Orlandini G; Stallone C
    Int J Artif Organs; 1998 Apr; 21(4):210-5. PubMed ID: 9649062
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Effect of membrane permeability on inflammation and arterial stiffness: a randomized trial.
    Li PK; Cheng YL; Leung CB; Szeto CC; Chow KM; Kwan BC; Ng ES; Fok QW; Poon YL; Yu AW
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):652-8. PubMed ID: 20203165
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Effects of high-flux hemodialysis on oxidant stress.
    Ward RA; Ouseph R; McLeish KR
    Kidney Int; 2003 Jan; 63(1):353-9. PubMed ID: 12472803
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Clinical performance of a new high-flux synthetic membrane.
    Hoenich NA; Stamp S
    Am J Kidney Dis; 2000 Aug; 36(2):345-52. PubMed ID: 10922313
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Serum beta 2-microglobulin levels in patients chronically dialyzed with CA-210 versus CT-190 dialysis membranes.
    DeFranco P; Farrell J; Gellens M; Bastani B
    Am J Nephrol; 1998; 18(1):16-20. PubMed ID: 9481434
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [LEVEL AND OXIDATION OF BETA 2-MICROGLOBULIN IN HEMODIALYSIS PATIENTS TREATED WITH INTRAVENOUS IRON DURING DIALYSIS WITH HIGH-FLUX COMPARED TO LOW-FLUX DIALYZERS].
    Michelis R; Sela S; Lanzmann A; Tanchilevski O; Shurtz-Swirski R; Kristal B
    Harefuah; 2017 May; 156(5):289-293. PubMed ID: 28551910
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Hemodiafiltration--a new treatment option for hyperphosphatemia in hemodialysis patients.
    Zehnder C; Gutzwiller JP; Renggli K
    Clin Nephrol; 1999 Sep; 52(3):152-9. PubMed ID: 10499310
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The effect of membrane biocompatibility on plasma beta 2-microglobulin levels in chronic hemodialysis patients.
    Hakim RM; Wingard RL; Husni L; Parker RA; Parker TF
    J Am Soc Nephrol; 1996 Mar; 7(3):472-8. PubMed ID: 8704114
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Synthetically modified cellulose (SMC): a cellulosic hemodialysis membrane with minimized complement activation.
    Bowry SK; Rintelen TH
    ASAIO J; 1998; 44(5):M579-83. PubMed ID: 9804499
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Influence of cellulose triacetate hemodialyzers on vancomycin pharmacokinetics.
    Welage LS; Mason NA; Hoffman EJ; Odeh RM; Dombrouski J; Patel JA; Swartz RD
    J Am Soc Nephrol; 1995 Oct; 6(4):1284-90. PubMed ID: 8589298
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Removal of silicon, aluminum and beta 2-microglobulin in chronic haemodialysis patients.
    Hosokawa S; Yoshida O
    Int Urol Nephrol; 1991; 23(3):281-4. PubMed ID: 1889973
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Clinical evaluation of a new dialyzer, FLX-12 GW, with a polyester-polymer alloy membrane.
    Stein G; Günther K; Sperschneider H; Carlsohn H; Hüller M; Schubert K; Schaller R
    Artif Organs; 1993 May; 17(5):339-45. PubMed ID: 8507169
    [TBL] [Abstract][Full Text] [Related]  

  • 97. High-flux dialysis membranes improve lipid profile in chronic hemodialysis patients.
    Blankestijn PJ; Vos PF; Rabelink TJ; van Rijn HJ; Jansen H; Koomans HA
    J Am Soc Nephrol; 1995 Mar; 5(9):1703-8. PubMed ID: 7780060
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Clearance of iopromide during haemodialysis with high- and low-flux membranes.
    Matzkies FK; Tombach B; Kisters K; Schuhmann G; Hohage H; Schaefer RM
    Acta Radiol; 1999 Mar; 40(2):220-3. PubMed ID: 10080739
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Pressure control of ultrafiltration rate with high-flux dialysis membranes.
    Kablitz C; Stephen RL; Zelman A; Harrow JJ; Deeter BR; Kolff WJ
    Artif Organs; 1981 May; 5(2):162-7. PubMed ID: 7023433
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The effect of dialyser membrane material on intradialytic changes in platelet count, platelet aggregation, circulating platelet aggregates and antithrombin III.
    Knudsen F; Nielsen AH; Kristensen SD
    Scand J Urol Nephrol; 1985; 19(3):227-32. PubMed ID: 4070991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.